XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Measurements [Abstract]  
Schedule of Company’s Liabilities that are Measured at Fair Value

The following table presents information about the Company’s liabilities that are measured at fair value as of March 31, 2025 and December 31, 2024 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

      March 31,   December 31, 
Description:  Level  2025   2024 
Derivative Liabilities:           
Forward purchase agreement  3  $1,134,400   $6,404,100 
Warrants – Series A  3  $689,500   $4,955,300 
Warrants – Series C and D  3  $11,031,300   $13,913,250 
Schedule of Fair Value Measurement of the FPA

The fair value measurement of the FPA at March 31, 2025 and December 31, 2024 was calculated using the following range of weighted average assumptions: 

 

   March 31,   December 31, 
   2025   2024 
Risk-free interest rate   3.91%   4.25%
Stock price  $6.00   $35.00 
Expected life   1.8 years    2.1 years 
Expected volatility of underlying stock   125.0%   105.0%
Dividends   0%   0%
Schedule of Determine the Fair Value

The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series A Warrants and Series B Warrants at the date of issuance (March 15, 2024), which included the following assumptions:

 

    Series A
Warrants
    Series B
Warrants
 
Expected term (in years)     5.7 years       5.7 years   
Stock price   $ 87.00     $ 87.00  
Risk free rate     4.2 %     4.2 %
Expected volatility     82.5 %     82.5 %
Expected dividend rate   $ 0.00     $ 0.00  
Exercise Price   $ 37.50     $ 0.01  

The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series A Warrants at March 31, 2025, which included the following assumptions:

 

    Series A Warrants  
Expected term     4.7 years  
Stock price   $ 6.00  
Risk free rate     4.0 %
Expected volatility     120.0 %
Expected dividend rate   $ 0.00  
Exercise Price   $ 16.37  

The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series C Warrants and Series D Warrants at the date of issuance on August 30, 2024, which included the following assumptions:

 

    Series C
Warrants
    Series D
Warrants
 
Expected term     5.6 years       5.6 years  
Stock price   $ 16.00     $ 16.00  
Risk free rate     3.7 %     3.7 %
Expected volatility     105.0 %     105.0 %
Expected dividend rate   $ 0.00     $ 0.00  
Exercise Price   $ 16.37     $ 0.0050  

The Company utilized a Monte Carlo simulation analysis to determine the fair value of the Series C Warrants and Series D Warrants at March 31, 2025, which included the following assumptions:

 

    Series C
Warrants
    Series D
Warrants
 
Expected term (in years)     5.7 years       5.7 years  
Stock price   $ 6.00     $ 6.00  
Risk free rate     4.0 %     4.0 %
Expected volatility     120.0 %     120.0 %
Expected dividend rate   $ 0.00     $ 0.00  
Exercise Price   $ 16.37     $ 0.0050  
Schedule of Recurring Basis Using Significant Unobservable Inputs (Level 3)

The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2025.

 

   Fair Value 
   Measurement 
   Using Level 3 
Forward Purchase Agreement  Inputs Total 
Balance, December 31, 2024  $6,404,100 
Change in fair value   (5,269,700)
Balance, March 31, 2025   1,134,400 

 

   Fair Value 
   Measurement 
   Using Level 3 
Warrants – Series A  Inputs Total 
Balance, December 31, 2024  $4,955,300 
Change in fair value   (4,265,800)
Balance, March 31, 2025   689,500 

 

   Fair Value 
   Measurement 
   Using Level 3 
Warrants – Series C and D  Inputs Total 
Balance, December 31, 2024  $13,913,250 
Change in fair value   (2,881,950)
Balance, March 31, 2025   11,031,300